Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection

Chinese Medical Journal

Volumn 123, Issue 10, 2010, Pages 1338-1344

  Lu, Yong Liang ^a   Wu, Xiao ^b   Huang, Hui Lian ^c   Dai, Li Cheng ^c  

^a HUZHOU UNIVERSITY   (China)

^b SIP Halo Biomaterial Technology Co Ltd   (China)

^c HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Hepatitis B virus; Hepatitis C virus; Interleukin 10; Meta analysis

Indexed keywords

INTERLEUKIN 10;

ARTICLE; ASIAN; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HEPATITIS B; HEPATITIS C; HUMAN; POPULATION GENETICS; RISK FACTOR; ALLELE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PROMOTER REGION;

ALLELES; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B; HEPATITIS C; HUMANS; INTERLEUKIN-10; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 77952935021     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.10.021     Document Type: Article

References (45)

1. Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008; 359: 1486-500.
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13: 2436-2441.
3. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993; 178: 1041-1048.
4. Tsukamoto H. Is interleukin-10 antifibrogenic in chronic liver injury? Hepatology 1998; 28: 1707-1709.
5. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
6. Reuss E, Fimmers R, Kruger A, Becker C, Rittner C, Hohler T. Differential regulation of interleukin-10 production by genetic and environmental factors - a twin study. Genes Immun 2002; 3: 407-413.
7. Westendorp RG, Langermans JA, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173.
8. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828-833.
9. Hurme M, Lahdenpohja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 1998; 30: 469-473.
10. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 3-19.
11. Höhler T, Reuss E, Freitag CM, Schneider PM. A functional polymorphism in the IL-10 promoter influences the response after vaccination with HbsAg and hepatitis A. Hepatology 2005; 42: 72-76.
12. Tseng LH, Lin MT, Shau WY, Lin WC, Chang FY, Chien KL, et al. Correlation of interleukin-10 gene haplotype with hepatocellular carcinoma in Taiwan. Tissue Antigens 2006; 67: 127-133.
13. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 2007; 357: 1210-1220.
14. Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, et al. The correlation between Kawasaki disease and polymorphisms of tumor necrosis factor alpha and interleukin-10 gene promoter. Chin J Pediatr (Chin) 2003; 41: 598-602.
15. Yan Y, Zhuo L. Genetic polymorphism of interleukin-10 in patients with hepatitis B infection. World J Gastroenterol 2006: 14: 3529-3533.
16. Peng XM, Huang YS, Ma HH, Gu L, Xie QF, Gao ZL. Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Liver Int 2006; 26: 326-333.
17. Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, et al. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 2009; 15: 5610-5619.
18. Zhang PA, Li Y, Yang XS. Associated study on interleukin 10 gene promoter polymorphisms related to hepatitis B virus infection in Chinese Han population. Chin J Med Genet (Chin) 2006; 23: 410-414.
19. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-a gene promoter polymorphisms. J Gastroenterol Hepatol 2006; 21: 1163-1169.
20. Yan Z, Tan W, Zhao W, Dan Y, Wang X, Mao Q, et al. Regulatory polymorphisms in the IL-10 gene promoter and HBV-related acute liver failure in the Chinese population. J Viral Hepat 2009; 16: 775-783.
21. Wang CJ, Shan KR, He Y, Zhang T, Li Y, Qi XL, et al. Study on the association of IL-10-592 polymorphism with susceptibility to hepatitis B Viral infection in Han, Yi and Yao ethnic groups in Guizhou province. Chin J Med Genet (Chin) 2008; 29: 444-448.
22. Mao XW, Yue W. Interleukin-10 gene polymorphisms with hepatitis C virus infection, illness and prognosis study. Clin Med China (Chin) 2006; 22: 1091-1093.
23. Bouzgarrou N, Hassen E, Farhat K, Bahri O, Gabbouj S, Maamouri N, et al. Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity. Hum Immunol 2009; 70: 230-236.
24. Abbas OM, Abdel-Rahman MH, Omar NA, Badran HM, Amir EM. Interleukin-10 promoter polymorphisms in hepatitis C patientswith and without Schistosomamansoni co-infection. Liver Int 2009; 29: 1422-1430.
25. Persico M, Capasso M, Persico E, Masarone M, Renzo A, Spano D, et al. Interleukin-10-1082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection. J Hepatol 2006; 45: 779-785.
26. Pereira FA, Pinheiro da Silva NN, Rodart IF, Carmo TM, Lemaire DC, Reis MG. Association of TGF-b1 codon 25 (G915C) polymorphism with hepatitis C virus infection. J Med Virol 2008; 80: 58-64.
27. Chuang JY, Yang SS, Lu YT, Hsieh YY, Chang SC, Chang CS, et al. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Dig Liver Dis 2009; 41: 424-430.
28. Chen TY, Hsieh YS, Wu TT, Yang SF, Wu CJ, Tsay GJ, et al. Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res 2007; 150: 116-1121.
29. Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, et al. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 2003; 55: 362-369.
30. Kusumoto K, Uto H, Hayashi K, Takahama Y, Nakao H, Suruki R, et al. Interleukin-10 or tumor necrosis factor-alpha polymorphisms and the natural course of hepatitis C virus infection in a hyperendemic area of Japan. Cytokine 2006; 34: 24-31.
31. Lio D, Caruso C, Di Stefano R, Colonna Romano G, Ferraro D, Scola L, et al. IL-10 and TNF-alpha polymorphisms and the recovery from HCV infection. Hum Immunol 2003; 64: 674-680.
32. Minton EJ, Smillie D, Smith P, Shipley S, McKendrick MW, Dermot C, et al. Clearance of Hepatitis C virus is not associated with single nucleotide polymorphisms in the IL-1, -6, or -10 Genes. Hum Immunol 2005; 66: 127-132.
33. Zeng JT, Liu ZW, Han QY, Zhang N. Genetic polymorphisms of interleukin-10 promoter region in patients with chronic HCV infection. J Xi'an Jiaotong Univ (Med Sci) (Chin) 2005; 1: 37-39.
34. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ, et al. The natural history of community-acquired hepatitis Cinthe United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-1905.
35. Zheng YH, Zhang CY, He Y, Zhou HY, Zou W, Ding PP, et al. The preliminary efficacy of interferon-a and ribavirin combination treatment of chronic hepatitis C in HIV-infected patients. Chin Med J 2005; 118: 1195-1200.
36. Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J 2009; 122: 98-102.
37. Bai L, Feng ZR, Lu HY, Li WG, Yu M, Xu XY. Prevalence of Antinuclear and Anti-liver-kidney-microsome Type-1 Antibodies In Patients With Chronic Hepatitis C In China. Chin Med J
38. Gu XB, Yang XJ, Wang D, Hua Z, Xu YQ, Lu ZH. Relationship between serum HBV DNA level and HBV-specific, nonspecific cytotoxic T lymphocytes and natural killer cells in patients with chronic hepatitis B. Chin Med J 2009; 122: 2129-2132.
39. Poynard T, Bedossa P, Opolon P. Natural history of liver fbrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-832.
40. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340: 1228-1233.
41. Diepolder HM, Zachoval R, Hoffmann RM, Jung MC, Gerlach T, Pape GR. The role of hepatitis C virus specifc CD4+ T lymphocytes in acute and chronic hepatitis C. J Mol Med 1996; 74: 583-588.
42. Cramp ME, Carucci P, Underhill J, Naoumov NV, Williams R, Donaldson PT. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia. J Hepatol 1998; 29: 207-213.
43. Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, et al. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 2003; 55: 362-369.
44. Zhu QR, Gu SQ, Yu H, Wang JS, Gu XH, Dong ZQ, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J 2005; 118: 1604-1609.
45. Jiang PJ, Zhao AM, Bao SM, Xiao SJ, Xiong M. Expression of chemokine receptors CCR3, CCR5 and CXCR3 on CD4+ T cells in CBA/JxDBA/2 mouse model, selectively induced by IL-4 and IL-10, regulates the embryo resorption rate. Chin Med J 2009; 122: 1917-1921.